Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Docosahexaenoic Acids | 41 | 2024 | 907 | 4.760 |
Why?
|
Lipoxins | 29 | 2017 | 419 | 2.640 |
Why?
|
Receptors, G-Protein-Coupled | 16 | 2023 | 1250 | 2.160 |
Why?
|
Inflammation Mediators | 20 | 2024 | 1884 | 2.120 |
Why?
|
Inflammation | 39 | 2024 | 10759 | 1.680 |
Why?
|
Phagocytosis | 22 | 2024 | 1526 | 1.580 |
Why?
|
Receptors, Lipoxin | 12 | 2012 | 83 | 1.480 |
Why?
|
Escherichia coli Infections | 9 | 2024 | 518 | 1.460 |
Why?
|
Macrophages | 28 | 2024 | 5758 | 1.420 |
Why?
|
Peritonitis | 16 | 2024 | 368 | 1.300 |
Why?
|
Aspirin | 29 | 2016 | 3127 | 1.140 |
Why?
|
Regeneration | 8 | 2021 | 1505 | 1.110 |
Why?
|
Neutrophils | 31 | 2024 | 3763 | 0.980 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 16 | 2016 | 2270 | 0.980 |
Why?
|
Receptors, Formyl Peptide | 10 | 2012 | 146 | 0.980 |
Why?
|
Hydroxyeicosatetraenoic Acids | 12 | 2003 | 224 | 0.980 |
Why?
|
Phagocytes | 6 | 2019 | 295 | 0.940 |
Why?
|
Eicosapentaenoic Acid | 13 | 2016 | 561 | 0.800 |
Why?
|
Escherichia coli | 11 | 2024 | 4210 | 0.780 |
Why?
|
Planarians | 3 | 2021 | 55 | 0.770 |
Why?
|
TNF Receptor-Associated Factor 3 | 1 | 2021 | 38 | 0.750 |
Why?
|
Staphylococcal Infections | 2 | 2022 | 1406 | 0.630 |
Why?
|
Leukotriene D4 | 2 | 2018 | 33 | 0.620 |
Why?
|
Staphylococcus aureus | 3 | 2022 | 1457 | 0.570 |
Why?
|
Lipids | 8 | 2016 | 3332 | 0.530 |
Why?
|
Carbon Monoxide | 3 | 2015 | 547 | 0.530 |
Why?
|
Thromboxane B2 | 5 | 2014 | 143 | 0.500 |
Why?
|
Fatty Acids, Omega-3 | 9 | 2022 | 1390 | 0.490 |
Why?
|
Cyclooxygenase Inhibitors | 3 | 2006 | 361 | 0.480 |
Why?
|
Lipid Metabolism | 9 | 2017 | 1896 | 0.470 |
Why?
|
Signal Transduction | 15 | 2021 | 23415 | 0.470 |
Why?
|
Anti-Inflammatory Agents | 8 | 2018 | 1810 | 0.460 |
Why?
|
Metabolome | 5 | 2018 | 988 | 0.430 |
Why?
|
Small Molecule Libraries | 1 | 2018 | 733 | 0.430 |
Why?
|
Animals | 78 | 2024 | 168202 | 0.430 |
Why?
|
Blood Vessels | 1 | 2018 | 1112 | 0.400 |
Why?
|
CHO Cells | 4 | 2018 | 1387 | 0.390 |
Why?
|
Cricetinae | 5 | 2018 | 2424 | 0.390 |
Why?
|
Cricetulus | 3 | 2018 | 814 | 0.380 |
Why?
|
Ligands | 13 | 2023 | 3268 | 0.370 |
Why?
|
Fatty Acids, Unsaturated | 6 | 2022 | 540 | 0.370 |
Why?
|
Heme Oxygenase-1 | 1 | 2013 | 366 | 0.360 |
Why?
|
Zymosan | 7 | 2024 | 134 | 0.340 |
Why?
|
Receptors, Cell Surface | 7 | 2003 | 2802 | 0.330 |
Why?
|
Mice | 49 | 2024 | 81368 | 0.320 |
Why?
|
Leukocytes | 8 | 2017 | 2024 | 0.300 |
Why?
|
Pharmacology | 2 | 2021 | 99 | 0.300 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 6 | 2004 | 318 | 0.300 |
Why?
|
Receptors, Leukotriene B4 | 5 | 2007 | 92 | 0.300 |
Why?
|
Receptors, Thromboxane | 2 | 1998 | 30 | 0.290 |
Why?
|
Structure-Activity Relationship | 5 | 2018 | 3074 | 0.290 |
Why?
|
Tandem Mass Spectrometry | 5 | 2023 | 1186 | 0.280 |
Why?
|
Sepsis | 3 | 2016 | 2585 | 0.260 |
Why?
|
Reperfusion Injury | 5 | 2018 | 1023 | 0.260 |
Why?
|
Molecular Conformation | 1 | 2006 | 544 | 0.250 |
Why?
|
Neutrophil Infiltration | 7 | 2016 | 390 | 0.240 |
Why?
|
Chromatography, Liquid | 6 | 2023 | 982 | 0.240 |
Why?
|
Lidocaine | 1 | 2008 | 538 | 0.240 |
Why?
|
Prostaglandins | 2 | 2015 | 398 | 0.240 |
Why?
|
Isoflurane | 1 | 2008 | 384 | 0.240 |
Why?
|
Isoenzymes | 6 | 2004 | 1687 | 0.230 |
Why?
|
Eicosanoids | 5 | 2022 | 282 | 0.220 |
Why?
|
Cells, Cultured | 18 | 2018 | 18937 | 0.220 |
Why?
|
Arachidonate 5-Lipoxygenase | 4 | 2018 | 128 | 0.220 |
Why?
|
Stereoisomerism | 8 | 2018 | 613 | 0.220 |
Why?
|
Exudates and Transudates | 3 | 2012 | 174 | 0.220 |
Why?
|
Cyclic AMP | 2 | 2018 | 1463 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3088 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3209 | 0.210 |
Why?
|
Monocytes | 4 | 2024 | 2565 | 0.200 |
Why?
|
Anesthetics | 1 | 2008 | 523 | 0.200 |
Why?
|
Oxylipins | 2 | 2022 | 53 | 0.200 |
Why?
|
Molecular Structure | 6 | 2016 | 1878 | 0.200 |
Why?
|
Humans | 83 | 2024 | 760740 | 0.200 |
Why?
|
Leukotriene B4 | 3 | 2018 | 280 | 0.190 |
Why?
|
Receptors, Chemokine | 3 | 2012 | 652 | 0.190 |
Why?
|
Cyclooxygenase 2 | 7 | 2005 | 596 | 0.180 |
Why?
|
Saliva | 1 | 2024 | 828 | 0.170 |
Why?
|
Leukotrienes | 2 | 2014 | 231 | 0.170 |
Why?
|
Recombinant Proteins | 8 | 2018 | 6520 | 0.170 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 1 | 2023 | 269 | 0.160 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 2 | 2019 | 614 | 0.160 |
Why?
|
Receptors, Leukotriene | 2 | 2018 | 95 | 0.150 |
Why?
|
Ciona intestinalis | 1 | 2018 | 10 | 0.150 |
Why?
|
Wound Healing | 4 | 2018 | 2802 | 0.150 |
Why?
|
Arrestins | 2 | 2015 | 73 | 0.150 |
Why?
|
Disease Models, Animal | 10 | 2024 | 18220 | 0.150 |
Why?
|
Hemorrhagic Disorders | 1 | 2017 | 34 | 0.150 |
Why?
|
Pneumonia, Pneumococcal | 2 | 2015 | 130 | 0.140 |
Why?
|
Major Histocompatibility Complex | 1 | 2000 | 870 | 0.140 |
Why?
|
Receptors, Prostaglandin | 1 | 1997 | 53 | 0.140 |
Why?
|
Peptides | 4 | 2007 | 4354 | 0.130 |
Why?
|
Tritium | 2 | 2015 | 706 | 0.130 |
Why?
|
Hypolipidemic Agents | 1 | 2000 | 609 | 0.130 |
Why?
|
MicroRNAs | 4 | 2013 | 3802 | 0.130 |
Why?
|
Aggressive Periodontitis | 1 | 2015 | 59 | 0.130 |
Why?
|
DNA Primers | 3 | 2015 | 2817 | 0.130 |
Why?
|
Molecular Sequence Data | 9 | 2006 | 17630 | 0.120 |
Why?
|
Staphylococcal Skin Infections | 1 | 2016 | 78 | 0.120 |
Why?
|
Binding Sites | 3 | 2018 | 6051 | 0.120 |
Why?
|
Sex Characteristics | 1 | 2005 | 2637 | 0.120 |
Why?
|
Receptor, Cannabinoid, CB2 | 1 | 2015 | 48 | 0.120 |
Why?
|
Lipoxygenases | 1 | 2014 | 13 | 0.120 |
Why?
|
Macrophage Activation | 1 | 2018 | 552 | 0.120 |
Why?
|
Oligopeptides | 1 | 2000 | 1185 | 0.120 |
Why?
|
Proteomics | 2 | 2008 | 3836 | 0.120 |
Why?
|
Fatty Acids | 1 | 2022 | 1808 | 0.110 |
Why?
|
Antimetabolites | 1 | 2014 | 129 | 0.110 |
Why?
|
Esters | 1 | 2015 | 211 | 0.110 |
Why?
|
Receptor, Cannabinoid, CB1 | 1 | 2015 | 137 | 0.110 |
Why?
|
Pharmaceutical Preparations | 2 | 2019 | 1086 | 0.110 |
Why?
|
Anti-Bacterial Agents | 1 | 2012 | 7403 | 0.110 |
Why?
|
Gene Silencing | 1 | 2019 | 1503 | 0.110 |
Why?
|
Acetylation | 2 | 2006 | 1055 | 0.110 |
Why?
|
Histamine H1 Antagonists | 1 | 2013 | 100 | 0.100 |
Why?
|
Cell Line | 9 | 2012 | 15577 | 0.100 |
Why?
|
Models, Immunological | 1 | 2014 | 512 | 0.100 |
Why?
|
Amides | 1 | 2015 | 449 | 0.100 |
Why?
|
Polymerase Chain Reaction | 4 | 2015 | 6074 | 0.100 |
Why?
|
Zebrafish Proteins | 1 | 2018 | 1013 | 0.100 |
Why?
|
Conjunctivitis, Allergic | 1 | 2013 | 125 | 0.100 |
Why?
|
Host-Pathogen Interactions | 2 | 2017 | 1454 | 0.090 |
Why?
|
Blood Coagulation | 1 | 2017 | 1154 | 0.090 |
Why?
|
Gene Expression Regulation | 9 | 2016 | 11874 | 0.090 |
Why?
|
Chemokine CXCL12 | 1 | 2013 | 454 | 0.090 |
Why?
|
Histamine | 1 | 2013 | 499 | 0.090 |
Why?
|
Apoptosis | 6 | 2016 | 9476 | 0.090 |
Why?
|
Amino Acid Sequence | 6 | 2005 | 13442 | 0.090 |
Why?
|
Microbial Viability | 1 | 2012 | 236 | 0.090 |
Why?
|
Acute Lung Injury | 1 | 2014 | 367 | 0.090 |
Why?
|
Gene Knockdown Techniques | 1 | 2015 | 1608 | 0.090 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 3 | 2023 | 858 | 0.090 |
Why?
|
RNA, Small Interfering | 1 | 2019 | 3419 | 0.090 |
Why?
|
Hypothermia | 1 | 2012 | 188 | 0.090 |
Why?
|
HEK293 Cells | 1 | 2019 | 4269 | 0.090 |
Why?
|
Goblet Cells | 1 | 2013 | 298 | 0.080 |
Why?
|
Spodoptera | 3 | 1998 | 141 | 0.080 |
Why?
|
Male | 32 | 2024 | 360402 | 0.080 |
Why?
|
Hematopoiesis | 1 | 2018 | 2049 | 0.080 |
Why?
|
Vancomycin | 1 | 2012 | 503 | 0.080 |
Why?
|
Mice, Knockout | 5 | 2018 | 14388 | 0.080 |
Why?
|
Calcium Signaling | 3 | 2013 | 734 | 0.080 |
Why?
|
Phosphorylation | 1 | 2019 | 8311 | 0.080 |
Why?
|
Ion Channels | 2 | 2023 | 1039 | 0.070 |
Why?
|
Cysteine | 2 | 2006 | 891 | 0.070 |
Why?
|
Parathyroid Hormone | 1 | 2014 | 1803 | 0.070 |
Why?
|
Sequence Homology, Amino Acid | 3 | 2003 | 2747 | 0.070 |
Why?
|
Alveolar Bone Loss | 2 | 2012 | 390 | 0.070 |
Why?
|
Baculoviridae | 2 | 1998 | 115 | 0.070 |
Why?
|
Metabolomics | 2 | 2014 | 1656 | 0.070 |
Why?
|
Corneal Neovascularization | 1 | 2009 | 185 | 0.070 |
Why?
|
Cell Communication | 1 | 2014 | 1654 | 0.070 |
Why?
|
Skin | 2 | 2018 | 4472 | 0.070 |
Why?
|
Cell Cycle Proteins | 1 | 2018 | 3447 | 0.070 |
Why?
|
Capillary Permeability | 2 | 2001 | 773 | 0.070 |
Why?
|
Analysis of Variance | 1 | 2015 | 6223 | 0.070 |
Why?
|
Radioligand Assay | 2 | 2005 | 366 | 0.070 |
Why?
|
Mass Spectrometry | 4 | 2005 | 2189 | 0.070 |
Why?
|
Biosynthetic Pathways | 2 | 2017 | 135 | 0.070 |
Why?
|
Immunologic Factors | 1 | 2015 | 1589 | 0.070 |
Why?
|
Hydrazines | 2 | 1998 | 223 | 0.060 |
Why?
|
Drug Design | 1 | 2011 | 1045 | 0.060 |
Why?
|
Periodontitis | 2 | 2012 | 568 | 0.060 |
Why?
|
Receptors, Growth Factor | 1 | 2006 | 326 | 0.060 |
Why?
|
Acute Disease | 5 | 2015 | 7236 | 0.060 |
Why?
|
Wounds and Injuries | 1 | 2018 | 2492 | 0.060 |
Why?
|
Phylogeny | 3 | 2010 | 2805 | 0.060 |
Why?
|
Membrane Proteins | 7 | 2004 | 7847 | 0.060 |
Why?
|
Cell Movement | 4 | 2007 | 5201 | 0.060 |
Why?
|
Organ Specificity | 2 | 2014 | 1964 | 0.060 |
Why?
|
Fatty Acids, Essential | 2 | 2015 | 97 | 0.060 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2006 | 220 | 0.060 |
Why?
|
Bone Marrow | 1 | 2014 | 2909 | 0.060 |
Why?
|
Microsomes | 2 | 2000 | 251 | 0.060 |
Why?
|
Rats | 6 | 2013 | 23716 | 0.060 |
Why?
|
RNA Interference | 1 | 2012 | 2829 | 0.060 |
Why?
|
Mice, Inbred C57BL | 3 | 2024 | 22117 | 0.050 |
Why?
|
Skin Diseases | 1 | 2012 | 1094 | 0.050 |
Why?
|
Mutagenesis, Site-Directed | 2 | 1997 | 1692 | 0.050 |
Why?
|
Angiogenesis Inhibitors | 2 | 2013 | 2048 | 0.050 |
Why?
|
Papio | 2 | 2015 | 669 | 0.050 |
Why?
|
Chemotaxis | 2 | 2018 | 598 | 0.050 |
Why?
|
Caseins | 1 | 2003 | 104 | 0.050 |
Why?
|
Cloning, Molecular | 3 | 1997 | 4172 | 0.050 |
Why?
|
Protein Binding | 4 | 2015 | 9345 | 0.050 |
Why?
|
Kinetics | 4 | 2002 | 6370 | 0.050 |
Why?
|
Models, Molecular | 3 | 2013 | 5433 | 0.050 |
Why?
|
Mice, Transgenic | 4 | 2014 | 9526 | 0.050 |
Why?
|
Substrate Specificity | 1 | 2006 | 1790 | 0.050 |
Why?
|
Molecular Targeted Therapy | 1 | 2013 | 2812 | 0.050 |
Why?
|
Bone and Bones | 1 | 2012 | 2565 | 0.050 |
Why?
|
Ear, External | 2 | 2000 | 165 | 0.050 |
Why?
|
Neutrophil Activation | 2 | 2002 | 180 | 0.050 |
Why?
|
Osteoclasts | 1 | 2005 | 711 | 0.050 |
Why?
|
Immunosuppressive Agents | 2 | 2013 | 4172 | 0.050 |
Why?
|
Coronary Disease | 1 | 2016 | 5911 | 0.050 |
Why?
|
Opioid Peptides | 1 | 2001 | 37 | 0.050 |
Why?
|
Placebos | 1 | 2005 | 1667 | 0.050 |
Why?
|
RNA, Messenger | 6 | 2009 | 12759 | 0.050 |
Why?
|
15-Oxoprostaglandin 13-Reductase | 1 | 2000 | 5 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2017 | 7995 | 0.050 |
Why?
|
Spleen | 3 | 2018 | 2286 | 0.050 |
Why?
|
Leukocytes, Mononuclear | 3 | 2015 | 1834 | 0.050 |
Why?
|
Porphyromonas gingivalis | 2 | 2015 | 164 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 4569 | 0.040 |
Why?
|
Binding, Competitive | 2 | 2001 | 1141 | 0.040 |
Why?
|
Monokines | 1 | 2000 | 71 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8652 | 0.040 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 3245 | 0.040 |
Why?
|
Chemokine CCL4 | 1 | 2000 | 126 | 0.040 |
Why?
|
Chemokine CXCL2 | 1 | 2000 | 106 | 0.040 |
Why?
|
Macrophage Inflammatory Proteins | 1 | 2000 | 121 | 0.040 |
Why?
|
Serum Amyloid A Protein | 1 | 2000 | 126 | 0.040 |
Why?
|
COS Cells | 2 | 2001 | 1130 | 0.040 |
Why?
|
Alcohol Oxidoreductases | 1 | 2000 | 168 | 0.040 |
Why?
|
Conserved Sequence | 1 | 2003 | 1162 | 0.040 |
Why?
|
Streptococcus pneumoniae | 2 | 2015 | 730 | 0.040 |
Why?
|
Arachidonic Acids | 1 | 2000 | 294 | 0.040 |
Why?
|
Dietary Fats, Unsaturated | 1 | 2000 | 224 | 0.040 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2010 | 2896 | 0.040 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2015 | 1333 | 0.040 |
Why?
|
Lung | 2 | 2015 | 9999 | 0.040 |
Why?
|
Base Sequence | 2 | 2003 | 12420 | 0.040 |
Why?
|
Quantum Theory | 1 | 2018 | 69 | 0.040 |
Why?
|
HL-60 Cells | 1 | 1999 | 364 | 0.040 |
Why?
|
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 1998 | 65 | 0.040 |
Why?
|
F2-Isoprostanes | 1 | 1998 | 35 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2003 | 1242 | 0.040 |
Why?
|
Oxidoreductases | 1 | 2000 | 412 | 0.040 |
Why?
|
Tunicamycin | 1 | 1998 | 108 | 0.040 |
Why?
|
Crosses, Genetic | 1 | 1999 | 750 | 0.040 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2001 | 661 | 0.040 |
Why?
|
Dinoprost | 1 | 1998 | 139 | 0.040 |
Why?
|
Immunity, Innate | 3 | 2017 | 3045 | 0.040 |
Why?
|
Rats, Sprague-Dawley | 2 | 2013 | 8165 | 0.040 |
Why?
|
Flow Cytometry | 1 | 2008 | 5863 | 0.040 |
Why?
|
Lymph Nodes | 3 | 2016 | 3461 | 0.040 |
Why?
|
Blood Platelets | 1 | 2008 | 2478 | 0.040 |
Why?
|
Knowledge Bases | 1 | 2017 | 97 | 0.040 |
Why?
|
Chromatography, High Pressure Liquid | 3 | 2011 | 1540 | 0.040 |
Why?
|
Prostaglandin Antagonists | 1 | 1997 | 28 | 0.040 |
Why?
|
DNA, Complementary | 2 | 2000 | 1989 | 0.040 |
Why?
|
Hindlimb | 1 | 1999 | 513 | 0.040 |
Why?
|
Dermatitis | 1 | 1999 | 202 | 0.030 |
Why?
|
Mice, Inbred BALB C | 5 | 2009 | 6188 | 0.030 |
Why?
|
Proteins | 2 | 2017 | 6030 | 0.030 |
Why?
|
3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 1997 | 74 | 0.030 |
Why?
|
Epoxy Compounds | 1 | 2016 | 137 | 0.030 |
Why?
|
Hydrogen Bonding | 1 | 1996 | 291 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2012 | 10754 | 0.030 |
Why?
|
Calcium | 2 | 2018 | 5717 | 0.030 |
Why?
|
Arachidonate 12-Lipoxygenase | 1 | 2015 | 82 | 0.030 |
Why?
|
Dexamethasone | 1 | 2002 | 1946 | 0.030 |
Why?
|
Liver | 2 | 2002 | 7512 | 0.030 |
Why?
|
Glycosylation | 1 | 1998 | 1098 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2000 | 3798 | 0.030 |
Why?
|
Monoacylglycerol Lipases | 1 | 2015 | 36 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2003 | 4340 | 0.030 |
Why?
|
Disulfides | 1 | 1996 | 464 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2013 | 16968 | 0.030 |
Why?
|
Amidohydrolases | 1 | 2015 | 158 | 0.030 |
Why?
|
Keratinocytes | 1 | 2018 | 790 | 0.030 |
Why?
|
Receptors, Histamine H1 | 1 | 2013 | 19 | 0.030 |
Why?
|
Lung Injury | 1 | 2018 | 422 | 0.030 |
Why?
|
Bodily Secretions | 1 | 2013 | 28 | 0.030 |
Why?
|
Homeostasis | 2 | 2015 | 3321 | 0.030 |
Why?
|
Receptor Cross-Talk | 1 | 2013 | 115 | 0.030 |
Why?
|
Peritoneal Cavity | 1 | 2012 | 135 | 0.030 |
Why?
|
Gene Expression | 3 | 2012 | 7569 | 0.030 |
Why?
|
Serine | 1 | 1996 | 830 | 0.030 |
Why?
|
Prostaglandin D2 | 1 | 2012 | 108 | 0.030 |
Why?
|
Ki-67 Antigen | 1 | 2014 | 627 | 0.030 |
Why?
|
Epitope Mapping | 1 | 2013 | 297 | 0.030 |
Why?
|
Administration, Inhalation | 1 | 2015 | 1156 | 0.030 |
Why?
|
Superoxides | 2 | 2005 | 387 | 0.020 |
Why?
|
Osteoprotegerin | 1 | 2012 | 176 | 0.020 |
Why?
|
Transcription Factor AP-1 | 1 | 2013 | 319 | 0.020 |
Why?
|
Sex Factors | 1 | 2006 | 10549 | 0.020 |
Why?
|
Swine | 2 | 2018 | 5908 | 0.020 |
Why?
|
Point Mutation | 1 | 1996 | 1595 | 0.020 |
Why?
|
Arthritis, Experimental | 1 | 2013 | 291 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2014 | 943 | 0.020 |
Why?
|
NF-kappa B | 2 | 2013 | 2481 | 0.020 |
Why?
|
Cyclooxygenase 1 | 2 | 2002 | 97 | 0.020 |
Why?
|
Glycoproteins | 1 | 1998 | 2200 | 0.020 |
Why?
|
Mice, Inbred Strains | 2 | 2005 | 1759 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2013 | 3492 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2013 | 13635 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2017 | 64572 | 0.020 |
Why?
|
3' Untranslated Regions | 1 | 2012 | 516 | 0.020 |
Why?
|
Models, Biological | 1 | 2006 | 9461 | 0.020 |
Why?
|
Female | 10 | 2018 | 392203 | 0.020 |
Why?
|
Drug Combinations | 1 | 2016 | 2048 | 0.020 |
Why?
|
Models, Chemical | 2 | 2003 | 611 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 1997 | 3793 | 0.020 |
Why?
|
Indomethacin | 2 | 2000 | 323 | 0.020 |
Why?
|
Dinoprostone | 1 | 2012 | 597 | 0.020 |
Why?
|
Drug Synergism | 1 | 2013 | 1756 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor C | 1 | 2009 | 127 | 0.020 |
Why?
|
Age Factors | 1 | 2005 | 18381 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2006 | 10203 | 0.020 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2009 | 427 | 0.020 |
Why?
|
Transfection | 3 | 2003 | 5765 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2000 | 4433 | 0.020 |
Why?
|
Immunity, Active | 1 | 2008 | 58 | 0.020 |
Why?
|
Leukocyte Rolling | 1 | 2008 | 69 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 1997 | 3730 | 0.020 |
Why?
|
Venules | 1 | 2008 | 161 | 0.020 |
Why?
|
Proteome | 1 | 2018 | 1857 | 0.020 |
Why?
|
L-Selectin | 1 | 2008 | 211 | 0.020 |
Why?
|
Electric Impedance | 1 | 2012 | 751 | 0.020 |
Why?
|
Fatty Alcohols | 1 | 2007 | 22 | 0.020 |
Why?
|
Glycols | 1 | 2007 | 55 | 0.020 |
Why?
|
Middle Aged | 5 | 2016 | 220603 | 0.020 |
Why?
|
Tumor Burden | 1 | 2013 | 1892 | 0.020 |
Why?
|
Osteoblasts | 1 | 2012 | 1141 | 0.020 |
Why?
|
Zebrafish | 1 | 2018 | 3005 | 0.020 |
Why?
|
Rats, Wistar | 2 | 2002 | 1848 | 0.020 |
Why?
|
Interleukin-10 | 1 | 2012 | 1171 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2009 | 546 | 0.020 |
Why?
|
Cytokines | 2 | 2013 | 7373 | 0.020 |
Why?
|
Osteogenesis | 1 | 2012 | 1270 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2003 | 10175 | 0.020 |
Why?
|
Enzyme Activation | 2 | 2003 | 3591 | 0.020 |
Why?
|
Blood | 1 | 2008 | 596 | 0.020 |
Why?
|
Protein Conformation | 1 | 2013 | 3965 | 0.020 |
Why?
|
Fibroblasts | 1 | 2016 | 4140 | 0.020 |
Why?
|
Transcription, Genetic | 2 | 2013 | 7583 | 0.020 |
Why?
|
Platelet Aggregation | 1 | 2008 | 771 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2013 | 3599 | 0.020 |
Why?
|
Mucous Membrane | 1 | 2008 | 659 | 0.010 |
Why?
|
Calgranulin B | 1 | 2005 | 86 | 0.010 |
Why?
|
Adult | 4 | 2014 | 220995 | 0.010 |
Why?
|
Metronidazole | 1 | 2005 | 232 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2015 | 3705 | 0.010 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2016 | 2746 | 0.010 |
Why?
|
Haptoglobins | 1 | 2005 | 165 | 0.010 |
Why?
|
Administration, Topical | 1 | 2005 | 703 | 0.010 |
Why?
|
Butadienes | 1 | 2003 | 107 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 1998 | 14649 | 0.010 |
Why?
|
Immune Sera | 1 | 2003 | 605 | 0.010 |
Why?
|
Up-Regulation | 1 | 2012 | 4117 | 0.010 |
Why?
|
Chemokines | 1 | 2007 | 954 | 0.010 |
Why?
|
Aged | 3 | 2016 | 169092 | 0.010 |
Why?
|
Lipid Peroxidation | 1 | 2003 | 271 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2015 | 3550 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2013 | 4910 | 0.010 |
Why?
|
Actins | 1 | 2010 | 2051 | 0.010 |
Why?
|
Calcimycin | 1 | 2002 | 213 | 0.010 |
Why?
|
Cell Adhesion Molecules | 1 | 2008 | 1602 | 0.010 |
Why?
|
Down-Regulation | 1 | 2009 | 2916 | 0.010 |
Why?
|
Jurkat Cells | 1 | 2003 | 740 | 0.010 |
Why?
|
Asthma | 1 | 2000 | 6234 | 0.010 |
Why?
|
Injections, Intradermal | 1 | 2001 | 116 | 0.010 |
Why?
|
Cerebral Arteries | 1 | 2003 | 490 | 0.010 |
Why?
|
Intracellular Fluid | 1 | 2001 | 201 | 0.010 |
Why?
|
Receptors, Opioid | 1 | 2001 | 145 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2005 | 2178 | 0.010 |
Why?
|
Chemotactic Factors | 1 | 2001 | 197 | 0.010 |
Why?
|
Anions | 1 | 2000 | 136 | 0.010 |
Why?
|
Depression, Chemical | 1 | 2000 | 184 | 0.010 |
Why?
|
Leukotriene C4 | 1 | 2000 | 79 | 0.010 |
Why?
|
Umbilical Veins | 1 | 2000 | 426 | 0.010 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2007 | 1650 | 0.010 |
Why?
|
Horses | 1 | 2000 | 300 | 0.010 |
Why?
|
Interleukin-1 | 1 | 2003 | 1248 | 0.010 |
Why?
|
Rabbits | 1 | 2005 | 4770 | 0.010 |
Why?
|
Phenobarbital | 1 | 1999 | 191 | 0.010 |
Why?
|
Ibuprofen | 1 | 1999 | 229 | 0.010 |
Why?
|
Ear Diseases | 1 | 2000 | 180 | 0.010 |
Why?
|
Nitriles | 1 | 2003 | 971 | 0.010 |
Why?
|
Adjuvants, Immunologic | 1 | 2003 | 990 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2015 | 22153 | 0.010 |
Why?
|
Androstanes | 1 | 1997 | 20 | 0.010 |
Why?
|
Cell Separation | 1 | 2003 | 1718 | 0.010 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 1999 | 321 | 0.010 |
Why?
|
Affinity Labels | 1 | 1997 | 107 | 0.010 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 1999 | 412 | 0.010 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 1999 | 446 | 0.010 |
Why?
|
Azasteroids | 1 | 1997 | 37 | 0.010 |
Why?
|
Azides | 1 | 1997 | 118 | 0.010 |
Why?
|
Brain | 1 | 2003 | 27100 | 0.010 |
Why?
|
Acetaminophen | 1 | 2000 | 555 | 0.010 |
Why?
|
Endothelium | 1 | 1999 | 764 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2013 | 9171 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2003 | 2639 | 0.010 |
Why?
|
NADP | 1 | 1997 | 227 | 0.010 |
Why?
|
Microcirculation | 1 | 2000 | 1272 | 0.010 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 1999 | 1169 | 0.010 |
Why?
|
Hepatocytes | 1 | 2002 | 1231 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2000 | 1624 | 0.010 |
Why?
|
Dendritic Cells | 1 | 2005 | 2722 | 0.010 |
Why?
|
Mutation | 1 | 1998 | 30015 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2003 | 5463 | 0.010 |
Why?
|
RNA | 1 | 2001 | 2713 | 0.010 |
Why?
|
Hippocampus | 1 | 2003 | 3762 | 0.010 |
Why?
|
Stem Cells | 1 | 2003 | 3514 | 0.010 |
Why?
|
Time Factors | 2 | 2003 | 39908 | 0.010 |
Why?
|
Sulfonamides | 1 | 1999 | 1977 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2003 | 11069 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2014 | 58919 | 0.000 |
Why?
|
Testosterone | 1 | 1997 | 2472 | 0.000 |
Why?
|
Neoplasms | 1 | 2013 | 22131 | 0.000 |
Why?
|
Neurons | 1 | 2003 | 9436 | 0.000 |
Why?
|